0

Met Receptor Tyrosine Kinase Transactivation Is Involved in Proteinase-Activated receptor-2-mediated Hepatocellular Carcinoma Cell Invasion

Roland Kaufmann, Claudia Oettel, Antje Horn, Karl-Jürgen Halbhuber, Annett Eitner, Reimar Krieg, Kathrin Katenkamp, Peter Henklein, Martin Westermann, Frank D Böhmer, Rithwik Ramachandran, Mahmoud Saifeddine, etc.

Carcinogenesis. 2009 Sep;30(9):1487-96.

PMID: 19546160

Abstract:

The expression of proteinase-activated receptor (PAR)(2) in human hepatocellular carcinoma (HCC) was established by reverse transcription-polymerase chain reaction, confocal immunofluorescence and electron microscopy in permanent cell lines, primary HCC cell cultures and HCC tumor tissue. Stimulation of HCC cells with trypsin and the PAR(2)-selective activating peptide, 2-furoyl-LIGRLO-NH(2), increased cell invasion across Matrigel. Both effects were blocked by a PAR(2)-selective pepducin antagonist peptide (pal-PAR(2)) and by PAR(2) silencing with specific small interfering RNA (siRNA). PAR(2)-initiated HCC cell invasion was also blocked by inhibiting the hepatocyte growth factor receptor (Met receptor tyrosine kinase) with the receptor-targeted kinase inhibitors, SU 11274 and PHA 665752, or by downregulation of Met with specific siRNA. The involvement of Met in PAR(2)-mediated HCC invasive signaling was further supported by the finding that treatment of HCC cells with trypsin or the PAR(2)-selective agonist peptide, 2-furoyl-LIGRLO-NH(2), stimulated Met activation-phosphorylation. In addition, Met-dependent stimulation of p42/p44 mitogen-activated protein Kinases was found to be critical for the PAR(2)-Met receptor tyrosine kinase-invasive signaling axis in HCC cells. Our study establishes an important link between the PAR(2) and Met receptor tyrosine kinase signaling in promoting HCC cell invasion.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP658084232-B SU 11274 SU 11274 658084-23-2 Price
qrcode